HQ-2304

N/A

Report date: 2026/03/24 20:00:35

Base Information

Drug NameHQ-2304
Drug Alias NameHQ2304HQ-2304
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUlcerStomach UlcerDuodenal Ulcer +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBaicheng Pharmaceutical (Zhuhai Hengqin) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBaicheng Pharmaceutical (Zhuhai Hengqin) Co LtdZhejiang Saimo Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsUlcerStomach UlcerDuodenal Ulcer +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A